Ibandronate Sodium Tablet, Film Coated
Product Images NDC 60429-643

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ibandronate Sodium (NDC 60429-643). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ibandronate-01 (Ibandronate 01)

Chemical structure of ibandronate sodium, displaying its molecular components and arrangement, including phosphonate groups and an alkyl chain with a nitrogen atom.*

FDA Label Image

Instructions1.jpg (Instructions1)

An instructional illustration showing a hand pressing on a circular tablet in a blister pack with an arrow indicating the direction to push for tablet removal. This aids users in proper tablet dispensing from the packaging.*

FDA Label Image

Instructions2.jpg (Instructions2)

An instructional illustration showing a hand pressing a tablet through the foil of a blister pack. An arrow points downward indicating the direction to push the tablet for removal.*

FDA Label Image

1081184 Ibandronate Film Coated Tablets 150mg 3 Carton United States Golden State Medical (GSM.jpg)

Packaging label for Ibandronate Sodium 150 mg film-coated tablets by Golden State Medical Supply, Inc. The label indicates a once-monthly oral dose with 3 packs containing one tablet per pack. The box includes storage instructions and a barcode, as well as the NDC 60429-643-73.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.